Your browser doesn't support javascript.
loading
Mediastinal Malignant Melanoma Markedly Shrinking in Response to Nivolumab.
Sakaguchi, Hiroyuki; Tanimoto, Azusa; Sato, Shigeki; Yanagimura, Naohiro; Suzuki, Chiaki; Takumi, Yohei; Nishiyama, Akihiro; Yamashita, Kaname; Takeuchi, Shinji; Ohtsubo, Koshiro; Yano, Seiji.
Afiliação
  • Sakaguchi H; Division of Medical Oncology, Cancer Research Institute, Kanazawa University, Japan.
  • Tanimoto A; Division of Medical Oncology, Cancer Research Institute, Kanazawa University, Japan.
  • Sato S; Division of Medical Oncology, Cancer Research Institute, Kanazawa University, Japan.
  • Yanagimura N; Division of Medical Oncology, Cancer Research Institute, Kanazawa University, Japan.
  • Suzuki C; Division of Medical Oncology, Cancer Research Institute, Kanazawa University, Japan.
  • Takumi Y; Division of Medical Oncology, Cancer Research Institute, Kanazawa University, Japan.
  • Nishiyama A; Division of Medical Oncology, Cancer Research Institute, Kanazawa University, Japan.
  • Yamashita K; Division of Medical Oncology, Cancer Research Institute, Kanazawa University, Japan.
  • Takeuchi S; Division of Medical Oncology, Cancer Research Institute, Kanazawa University, Japan.
  • Ohtsubo K; Division of Medical Oncology, Cancer Research Institute, Kanazawa University, Japan.
  • Yano S; Division of Medical Oncology, Cancer Research Institute, Kanazawa University, Japan.
Intern Med ; 61(1): 75-79, 2022 Jan 01.
Article em En | MEDLINE | ID: mdl-34176837
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Melanoma Limite: Aged / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Melanoma Limite: Aged / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article